Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 27, 2017
Pharmacy Choice - News - Front Page Healthcare News - June 27, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/20/17 - Gainers & Losers Of June 19: ARNA, NVDQ, CLVS, RWLK, CLSN...
WASHINGTON- The following are some of the biotech stocks that made their way onto the Day's Gainers& Losers' list of June 19, 2017. News: The Company has agreed to be acquired by Stryker Corp.. Stryker has agreed to acquire Novadaq for US $11.75 per share in cash, implying a total equity value of approximately US $701 million.
6/20/17 - Global Needle-Free Drug Delivery Market 2017-2021: Endo Pharmaceuticals, Antares Pharma, Inovio Pharmaceuticals, Valeritas, PharmaJet
The market is divided into the following segments based on geography:- Americas- APAC- EMEA. Key vendors- Endo Pharmaceuticals- Antares Pharma- Inovio Pharmaceuticals- Valeritas- PharmaJet. Other prominent vendors- 3 M- Akra Dermojet- Consort Medical- CROSSJECT- Injex Pharma- PenJet Corporation- Zosano- DAntonio Consultants International- European
6/20/17 - Immunicum Announces Publication in Journal for ImmunoTherapy of Cancer of Results Overview from Ilixadencel's First Clinical Study in Metastatic Renal Cell Carcinoma
Press Release 20 June 2017 Immunicum Announces Publication in Journal for ImmunoTherapy of Cancer of Results Overview from Ilixadencel's First Clinical Study in Metastatic Renal Cell Carcinoma Immunicum AB, a biopharmaceutical company advancing a novel immuno-oncology treatment against a range of solid tumors, today announced that the results from.
6/19/17 - "High-Definition Particle Detection during Centrifugation" in Patent Application Approval Process (USPTO 20170153431)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Nguyen, Hoang Thanh; Noolandi, Jaan; Schultheis, Robert James, filed on November 28, 2016, was made available online on June 8, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application ha
6/19/17 - "Laboratory Instrument & Method of Using the Same" in Patent Application Approval Process (USPTO 20170153260)
By a News Reporter-Staff News Editor at Robotics& Machine Learning A patent application by the inventors Barmettler, Kurt; Peter, Andre, filed on November 29, 2016, was made available online on June 8, 2017, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent application has not been assigned
6/19/17 - 'Repeal and replace' plan forces state-run exchanges to grapple with uncertain future
As Congress plans the repeal of Obamacare, government websites set up to sell insurance under the program are beginning to grapple with an uncertain future and whether they can adapt to a GOP model down the road. Yet, they're also the "front-door" for determining whether customers qualify for the federal-state Medicaid program or tax credits on the
6/19/17 - 15 Stocks Moving In Monday's Pre-Market Session
Chardan Capital upgraded Clovis Oncology from Sell to Neutral. Rice Energy Inc shares rose 27.2 percent to $25.05 in pre-market trading as EQT Corporation announced plans to buy the company for $6.7 billion. Rigel Pharmaceuticals, Inc. rose 14 percent to $2.85 in pre-market trading after the company disclosed that its New Drug Application for TAVAL
6/19/17 - 3M Tegaderm CHG I.V. Securement Dressing Receives FDA 510k Clearance for Expanded Indication to Reduce Catheter-Related Bloodstream Infection
By a News Reporter-Staff News Editor at Clinical Trials Week Catheter-related bloodstream infections are life-threatening for patients and costly for the medical professionals and facilities caring for them. 3 M is pleased to announce that the U.S. Food and Drug Administration has recognized the efficacy of 3 M? Tegaderm? CHG Chlorhexidine Gl
6/19/17 - A Blueprint for Success in Value-based Care
By a News Reporter-Staff News Editor at Journal of Engineering Remedy Partners, the episodes of care company and provider of data-driven technology and services for value-based care, announced results that demonstrate the positive impact of bundled payments. Remedy Partners delivers proven value-based care solutions that enable payers, employers
6/19/17 - AbbVie's Upadacitinib ABT-494 Meets All Primary and Ranked Secondary Endpoints in Phase 3 Study in Rheumatoid Arthritis
By a News Reporter-Staff News Editor at Clinical Trials Week AbbVie, a global biopharmaceutical company, announced positive top-line results from the Phase 3 SELECT-NEXT clinical trial evaluating upadacitinib, an investigational oral JAK1-selective inhibitor, in patients with moderate to severe rheumatoid arthritis who did not adequately respond
6/19/17 - Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego
By a News Reporter-Staff News Editor at Clinical Trials Week Active Implants, a company that develops orthopedic implant solutions, announced that the company's SUN trial is now underway in San Diego. Scott A. Hacker at Grossmont Orthopaedic Medical Group is the only physician in San Diego County- and the center is one of just 10 sites nationwide
6/19/17 - Addiction Treatment Leader JourneyPure Reduces Relapse with JourneyPure Coaching Program, Adds New Gamification Features to App
By a News Reporter-Staff News Editor at Mental Health Weekly Digest JourneyPure, a pioneer in addiction treatment services, announced that its proprietary JourneyPure Coaching? program and technology are promoting higher patient engagement and lower relapse rates compared to industry averages. Through a combination of inpatient facilities,...
6/19/17 - After Passing Several Innovative Health Policies, Nevada Reaches Its Limit: Medicaid for All [Governing]
June 19 In the sparsely populated state of Nevada, Republican Gov. Meanwhile, the GOP Congress remains gridlocked in its negotiations to repeal and replace the Affordable Care Act, President Obama's signature legislation. But the days of cross-party agreement on health care have reached a limit in Nevada.
6/19/17 - Agency Information Collection Activities; Proposed Collection; Comment Request; Disclosures of Descriptive Presentations in Professional Oncology...
SUMMARY: The Food and Drug Administration is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for publ
6/19/17 - Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs; Common European Medicines Agency/Food and Drug...
SUMMARY: The Food and Drug Administration is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed...
6/19/17 - AHA Letter to the Senate Regarding AHCA Deliberations
Washington- June 19, 2017- On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinical partners- including more than 270,000 affiliated physicians, 2 million nurses and other caregivers- and the 43,000 health care leaders who belong to our professional membership groups, the American Hospital
6/19/17 - AHCA is unfair, unaffordable: Montanans age 50 to 64 would dig deeper into their pockets to pay for health insurance
Under the AHCA, insurance companies can charge older adults five times what other consumers pay for the same health insurance policy. The bill also lets Montana lawmakers get a waiver that would give insurance companies the power to charge older adults even more. ?A 55- year-old Montanan earning $25,000 annually could see his or her premium incre
6/19/17 - Aldeyra Therapeutics Announces First Patient Enrolled in Dry Eye Disease Phase 2a Clinical Trial
By a News Reporter-Staff News Editor at Clinical Trials Week Aldeyra Therapeutics, Inc., a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related to aldehydes, announced that it has enrolled the first patient into a Phase 2 a clinical trial of topical ocular ADX-102 for the t
6/19/17 - Alectinib halts lung cancer growth more than a year longer than crizotinib
By a News Reporter-Staff News Editor at Clinical Trials Week ASCO Perspective. The study will be featured in a press briefing today and presented at the 2017 American Society of Clinical Oncology Annual Meeting. "This is the first global study to compare alectinib with crizotinib in ALK-positive lung cancer and establishes alectinib as the new s
6/19/17 - Alkermes Announces Initiation of Phase 3 Study of ALKS 3831 in Young Adult Patients
By a News Reporter-Staff News Editor at Biotech Business Week Alkermes plc announced the initiation of ENLIGHTEN-Early, a supportive study in the ENLIGHTEN clinical development program for ALKS 3831, an investigational, novel, once-daily, oral atypical antipsychotic drug candidate designed to be a broad-spectrum treatment for schizophrenia.
6/19/17 - All Vaccine Market Report 2017 | Manufacturers, Countries, Type and Application, Forecast to 2022
All Vaccine MarketReport offered by DecisionDatabases.com gives a market overview of the All Vaccine industry which covers product scope, market revenue, opportunities, growth rate, sales volumes and figures. The report also explores the wo...
6/19/17 - America needs to make health care affordable again
Whether the American Health Care Act, which narrowly passed the U.S. House of Representatives last month, offers an effective repeal and replacement of the Affordable Care Act- affectionately known as Obamacare- is the subject of much debate as the Senate takes up another attempt to deal with the failed health-care fiasco. Recent analysis by the U.
6/19/17 - Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab
By a News Reporter-Staff News Editor at Pharma Business Week Amgen and Allergan plc. announced that the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration will review data supporting the Biologics License Application for ABP 215, a biosimilar candidate to Avastin , on July 13, 2017. The FDA has set a Biosimilar User Fee
6/19/17 - Amgen Presents New Phase 2 Data On IMLYGIC Talimogene Laherparepvec Investigational Combination At ASCO 2017
By a News Reporter-Staff News Editor at Biotech Business Week Amgen announced new data from the Phase 2' 264 study that demonstrated IMLYGIC in combination with the immune checkpoint inhibitor YERVOY * more than doubled objective response rate, defined as the proportion of patients with tumor size reduction, compared to YERVOY alone in patie
6/19/17 - Amgen Submits Regulatory Applications For Repatha evolocumab Cardiovascular Outcomes Data In US And Europe
By a News Reporter-Staff News Editor at Pharma Business Week Amgen announced the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration and a variation to the marketing authorization to the European Medicines Agency for Repatha , a PCSK9 inhibitor. This demonstrates a significant unmet need, as event
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415